Institute of Cardiovascular Sciences, University of Birmingham, Birmingham B15 2TT, UK; Guangdong Cardiovascular Institute, Guangdong General Hospital, Guangdong Academy of Medical Science, Guangzhou 510100, PR China.
Institute of Cardiovascular Sciences, University of Birmingham, Birmingham B15 2TT, UK.
Arch Cardiovasc Dis. 2019 Mar;112(3):171-179. doi: 10.1016/j.acvd.2018.10.006. Epub 2019 Jan 22.
Female sex has been linked with worse prognosis in patients with atrial fibrillation (AF). Clinical risk stratification of women with AF may help decision-making before catheter ablation (CA).
To evaluate arrhythmia outcomes and the predictive value of clinical scores for arrhythmia recurrence in a large cohort of Chinese patients with AF undergoing CA.
A total 1410 of patients (68.1% men) who underwent AF ablation with scheduled follow-up were analysed retrospectively. Baseline characteristics and ablation outcome were compared between men and women. The predictive values of risk scoring systems for AF recurrence were assessed in women.
Recurrence, early recurrence and complications after CA were similar in women and men over similar follow-up periods (20.7±8.0 vs 20.7±9.1 months; P>0.05). Compared with men, women with AF recurrence were older and had a larger left atrial diameter (LAD), less paroxysmal AF, lower left ventricular ejection fraction, lower estimated glomerular filtration rate (eGFR) and higher serum concentrations of B-type natriuretic peptide (BNP) and C-reactive protein (CRP) (all P<0.01). Multivariable analysis showed that age, non-paroxysmal AF, body mass index, coronary artery disease, LAD, early recurrence, eGFR, BNP and CRP were independent risk factors with sex differences (all P<0.05) in the whole cohort. In women, only non-paroxysmal AF, early recurrence, BNP, CRP (all P<0.01) and history of stroke/transient ischaemic attack (P=0.016) were independent risk factors. Of the clinical scoring systems tested, MB-LATER, APPLE, CAAP-AF and BASE-AF scores (C-indexes 0.73, 0.72, 0.68 and 0.72, respectively; all P<0.01) had a modest predictive value for AF recurrence after CA in women.
CA for AF has similar recurrence risks in women and men, but there are sex differences in the clinical characteristics and risk factors associated with AF recurrence.
女性的性别与心房颤动(AF)患者的预后较差有关。对 AF 女性患者进行临床风险分层有助于在导管消融(CA)前做出决策。
评估在中国接受 CA 的大量 AF 患者中,心律失常结局和临床评分对心律失常复发的预测价值。
回顾性分析了 1410 例(68.1%为男性)接受 AF 消融并进行了预定随访的患者。比较了男性和女性之间的基线特征和消融结果。评估了风险评分系统在女性中的 AF 复发预测价值。
在相似的随访期内,女性和男性的 CA 后复发、早期复发和并发症相似(20.7±8.0 与 20.7±9.1 个月;P>0.05)。与男性相比,AF 复发的女性年龄较大,左心房直径(LAD)较大,阵发性 AF 较少,左心室射血分数较低,估算肾小球滤过率(eGFR)较低,血清 B 型利钠肽(BNP)和 C 反应蛋白(CRP)浓度较高(均 P<0.01)。多变量分析显示,年龄、非阵发性 AF、体重指数、冠状动脉疾病、LAD、早期复发、eGFR、BNP 和 CRP 是整个队列中具有性别差异的独立危险因素(均 P<0.05)。在女性中,只有非阵发性 AF、早期复发、BNP、CRP(均 P<0.01)和中风/短暂性脑缺血发作史(P=0.016)是独立的危险因素。在测试的临床评分系统中,MB-LATER、APPLE、CAAP-AF 和 BASE-AF 评分(C 指数分别为 0.73、0.72、0.68 和 0.72;均 P<0.01)对女性 CA 后 AF 复发具有适度的预测价值。
CA 治疗 AF 在女性和男性中的复发风险相似,但与 AF 复发相关的临床特征和危险因素存在性别差异。